"Designing Growth Strategies is in our DNA"
The global thrombin market size was valued at USD 535.0 Million in 2018, is projected to reach USD 738.7 Million by the end of 2026, exhibiting a CAGR of 4.1%.
According to data published by the Journal of Emergency Medical Services (JEMS), every year, an estimated 5.0 million people succumb to traumatic and non-traumatic hemorrhage, worldwide. Thrombin is a type of protein enzyme that plays a major role in hemostasis and thrombosis. Also, it activates cellular factors in platelets which enhances the process of hemostasis.
Moreover, thrombin plays a major part in wound healing and recovery process. Deep vein thrombosis, pulmonary thrombosis, and femoral vein thrombosis are commonly observed types of thrombosis across the world. Certain factors such as smoking, aging, cancer, heart failure, and sedentary life style can lead to thrombosis. Growing adoption of hemostats in excessive bleeding during surgical procedures and rising emphasis on prevention of thrombosis are prominently driving the thrombin market growth.
Request a sample to learn more about this report.
"Bovine Thrombin is Most Attractive Product Type"
The factors such as growing prevalence of inherited blood clotting disorder, obesity and rising adoption of smoking have led to growth in prevalence of thrombosis, which will eventually increase the demand for thrombin like hemostats during forecast period. Leading players in the market are focusing on serving the therapeutic thrombin products within minimal costs, most considerably bovine sourced thrombin products.
To know how our report can help streamline your business, Speak to Analyst
Bovine thrombin segment accounted for a thrombin market share of 51.8% in 2018. High share of the segment is attributed to greater adoption of bovine sourced thrombin products in several applications such as therapeutic, diagnostic and academic research. In terms of dosage form, solution form is likely to be the fastest growing segment for the forecast duration, owing to the proven clinical efficacy and better stability than powder form.
"North America and Asia Pacific Emerge as Lucrative Market for Thrombin"
North America generated a value of USD 307.9 Mn in 2018, and is anticipated to emerge dominant in global market during the forecast period. The Market in the North America is driven by factors such as, strong presence of major players such as Pfizer, Inc., Ethicon (subsidiary of Johnson & Johnson Services Inc.) and others.
North America Thrombin Market, 2018
To get more information on the regional analysis of this market, Request a sample
Moreover, aging population, rising healthcare expenditures, increasing emphasis on better patient outcomes, and lucrative reimbursement policies are driving the thrombin market growth in North America region. Asia Pacific also holds huge potential for growth of the market owing to considerable adoption of thrombin based hemostats in countries such as Japan and China.
"Pfizer to Account for More Than Half of the Market Share in Terms of Revenue"
Pfizer emerged as the leading player with the highest thrombin market share in 2018, as the company is engaged in offering most commonly used thrombin based hemostats called Thrombin JMI. Combined with this, the company has strong focus on reinforcing strategies for development of robust distribution network and strong penetration in market of North America.
In March 2018, Baxter completed acquisition of hemostatic portfolio from Mallinckrodt Pharmaceuticals that take account of Recothrom, the only commercial recombinant thrombin brand available in market. Some of the major companies that are present in the global thrombin industry are Pfizer Inc., Johnson & Johnson Services Inc., Baxter, Shanghai RAAS blood products co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co., Ltd.
Hemostats improve hemostasis by boosting the primary hemostasis process and by vitalizing fibrin formation. Thrombin hemostats are active hemostats and act by interfering with blood clotting cascade. Thrombin JMI and Recothrom are most commonly used thrombin based brands in the U.S. since a decade. Adoption of these brands in the U.S. is expected to support the growth of global thrombin market during the forecast period.
The report provides qualitative and quantitative insights in thrombin market and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented by product type, dosage form, and end user. On the basis of product type, the market is categorized into bovine thrombin, human thrombin, and recombinant thrombin. Based on the dosage form, the market is segmented into powder and solution form.
Various end users covered in the report are hospitals, diagnostics centers & clinics, and academics and research institutes. Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, and Rest of the World. The regions are further categorized into countries.
To gain extensive insights into the market, Request for Customization
Along with this, the report provides an elaborative analysis of thrombin industry dynamics and competitive landscape. Various key insights provided in the report are key brand analysis, key industry developments - mergers, acquisitions and partnerships, reimbursement scenario, and key performance indicators for the thrombin market.
· Bovine Thrombin
· Human Thrombin
· Recombinant Thrombin
By Dosage Form
· Powder Form
· Solution Form
By End user
· Diagnostics Centers & Clinics
· Academics and Research Institutes
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
· Asia Pacific (Japan, China, Australia, and Rest of Asia Pacific)
· Rest of the World
Fortune Business Insights says that the Thrombin Market was valued at US$ 535.0 Mn in 2018 and is projected to reach US$ 737.8 Mn by 2026.
In 2018, the Thrombin Market was valued at US$ 535.0 Mn.
Growing at a CAGR of 4.1%, the Thrombin Market will exhibit steady growth in the forecast period (2019-2026)
Bovine Thrombin segment is expected to be the leading segment in Thrombin Market during the forecast period.
Growing prevalence of inherited blood clotting disorder and growth in prevalence of thrombosis are some of the factors anticipated drive the growth of the Thrombin Market.
Pfizer is the leading player in Thrombin Market.
North America is expected to hold the highest market share in the Thrombin Market.
Lucrative reimbursement policies would drive the adoption of Thrombin.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry